NCT03628391 - Haloperidol for Delirium in Adult Critically Ill Patients | Biotech Hunter

Enrollment

142

Participants

Timeline

Start Date

February 22, 2018

Primary Completion Date

February 3, 2020

Study Completion Date

January 23, 2021

Conditions

DeliriumCritical IllnessIntensive Care PsychosisCognitive ImpairmentCognitive Decline

Interventions

DRUG

Haloperidol

haloperidol for ICU delirium, titrated on validated screening tool-based diagnosis

DRUG

Placebo

placebo for ICU delirium, titrated on validated screening tool-based diagnosis

Trial Locations (8)

Jeroen Bosch ziekenhuis, 's-Hertogenbosch

IJsselland Hospital, Capelle aan den IJssel

Albert Schweitzer Hospital, Dordrecht

Radboudumc, Nijmegen

ErasmusMC, Rotterdam

Franciscus Gasthuis (Hospital), Rotterdam

Ikazia Hospital, Rotterdam

Maasstad Hospital, Rotterdam